Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021-Reference-Cited by-同舟云学术

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021

Published:2022-06-27 Issue:8 Volume:18 Page:465-479
ISSN:1759-4790
Container-title:Nature Reviews Rheumatology
language:en
Short-container-title:Nat Rev Rheumatol

Author:

Coates Laura C.^ORCID,Soriano Enrique R.,Corp Nadia,Bertheussen Heidi,Callis Duffin Kristina,Campanholo Cristiano B.,Chau Jeffrey^ORCID,Eder Lihi,Fernández-Ávila Daniel G.,FitzGerald Oliver^ORCID,Garg Amit,Gladman Dafna D.^ORCID,Goel Niti,Helliwell Philip S.,Husni M. Elaine,Jadon Deepak R.^ORCID,Katz Arnon,Laheru Dhruvkumar,Latella John,Leung Ying-Ying^ORCID,Lindsay Christine^ORCID,Lubrano Ennio^ORCID,Mazzuoccolo Luis Daniel^ORCID,Mease Philip J.^ORCID,O’Sullivan Denis,Ogdie Alexis,Olsder Wendy,Palominos Penelope Esther,Schick Lori,Steinkoenig Ingrid,de Wit Maarten^ORCID,van der Windt D. A.,Kavanaugh Arthur,Campanholo Cristiano,Fitzgerald Oliver,Gladman Dafna,Helliwell Philip,Husni M. Elaine,Laheru Dhrukumar,Leung Ying-Ying,Lubrano Ennio,Mazzuoccolo Luis Daniel,Mease Philip J.,Ogdie Alexis,Palominos Penelope Esther,

Publisher

Springer Science and Business Media LLC

Subject

Rheumatology

Link

https://www.nature.com/articles/s41584-022-00798-0.pdf

Reference49 articles.

1. Ritchlin, C. T. et al. Treatment recommendations for psoriatic arthritis. Ann. Rheum. Dis. 68, 1387–1394 (2009).

2. Coates, L. C. et al. Group for research and assessment of psoriasis and psoriatic arthritis: treatment recommendations for psoriatic arthritis 2015. Arthritis Rheumatol. 68, 1060–1071 (2016).

3. Guyatt, G. H. et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336, 924–926 (2008).

4. Coates, L. C., Corp, N., van der Windt, D. A., Soriano, E. R. & Kavanaugh, A. GRAPPA treatment recommendations: an update from the 2020 GRAPPA annual meeting. J. Rheumatol. Suppl. 97, 65–66 (2021).

5. Higgins, J. P. T. et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343, d5928 (2011).

Cited by 166 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Continuous improvement through differential trajectories of individual minimal disease activity criteria with guselkumab in active psoriatic arthritis: post hoc analysis of a phase 3, randomized, double-blind, placebo-controlled study;BMC Rheumatology;2024-02-04

2. Existing and Emerging Targeted Therapies in Juvenile Psoriatic Arthritis: Challenges and Unmet Needs;Pediatric Drugs;2024-02-04

3. A clinical review of structural damage in psoriatic arthritis for dermatologists: From pathogenesis to ongoing controversies;Journal of the American Academy of Dermatology;2024-02

4. Difficult-to-treat psoriatic arthritis: moving out of the rheumatoid arthritis shadow;Nature Reviews Rheumatology;2024-01-26

5. Effectiveness of Tofacitinib in Patients Initiating Therapy for Psoriatic Arthritis: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry;Rheumatology and Therapy;2024-01-22